3005 Risk of mortality in patients with cancer experiencing febrile neutropenia
Publication
, Conference
Lyman, GH; Michels, SL; Tomic, KE; Yu, J; Reynolds, MW; Barron, RL
Published in: European Journal of Cancer Supplements
September 2009
Duke Scholars
Published In
European Journal of Cancer Supplements
DOI
ISSN
1359-6349
Publication Date
September 2009
Volume
7
Issue
2
Start / End Page
176 / 177
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., Michels, S. L., Tomic, K. E., Yu, J., Reynolds, M. W., & Barron, R. L. (2009). 3005 Risk of mortality in patients with cancer experiencing febrile neutropenia. In European Journal of Cancer Supplements (Vol. 7, pp. 176–177). Elsevier BV. https://doi.org/10.1016/s1359-6349(09)70604-4
Lyman, G. H., S. L. Michels, K. E. Tomic, J. Yu, M. W. Reynolds, and R. L. Barron. “3005 Risk of mortality in patients with cancer experiencing febrile neutropenia.” In European Journal of Cancer Supplements, 7:176–77. Elsevier BV, 2009. https://doi.org/10.1016/s1359-6349(09)70604-4.
Lyman GH, Michels SL, Tomic KE, Yu J, Reynolds MW, Barron RL. 3005 Risk of mortality in patients with cancer experiencing febrile neutropenia. In: European Journal of Cancer Supplements. Elsevier BV; 2009. p. 176–7.
Lyman, G. H., et al. “3005 Risk of mortality in patients with cancer experiencing febrile neutropenia.” European Journal of Cancer Supplements, vol. 7, no. 2, Elsevier BV, 2009, pp. 176–77. Crossref, doi:10.1016/s1359-6349(09)70604-4.
Lyman GH, Michels SL, Tomic KE, Yu J, Reynolds MW, Barron RL. 3005 Risk of mortality in patients with cancer experiencing febrile neutropenia. European Journal of Cancer Supplements. Elsevier BV; 2009. p. 176–177.
Published In
European Journal of Cancer Supplements
DOI
ISSN
1359-6349
Publication Date
September 2009
Volume
7
Issue
2
Start / End Page
176 / 177
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis